Unimedic AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Unimedic AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10929
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Unimedic AB (Unimedic), formerly Ergobe Pharma AB, a subsidiary of MedCap AB, is a pharmaceutical company which develops, manufactures, distributes and markets pharmaceutical products. The company offers non-licensed, extemporaneous, and licensed pharmaceuticals targeting the therapy areas which include anesthesiology or intensive care, gastroenterology, immunoglobulins or transplant, and drug addiction treatment. It also provides services including contract development, validation, chemical and microbiological analyses of active raw materials (API), excipients, water for injection (WFI) and finished products; performs stability studies; and formulation development from laboratory scale batches up to full scale batches. Unimedic also supplies imported pharmaceuticals to pharmacies; and provides repackaging services for medical products, dietary supplements, cosmetics or medical devices, and clinical trials. The company partners with academics, industry and the health care sectors. Unimedic is headquartered in Matfors, Sweden.

Unimedic AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Unimedic AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Unimedic AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Unimedic AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Unimedic Enters into Distribution Agreement with Mylan 10
Licensing Agreements 11
Unimedic Pharma Enters into Licensing Agreement with Basilea Pharma 11
Unimedic Enters into Licensing Agreement with Martindale Pharma 12
Acquisition 13
Unimedic Acquires Miwana 13
Unimedic Acquires Cross Pharma From Medivir For USD18.6 Million 14
Unimedic Acquires Pharmadone 15
Unimedic Acquires Ergobe Pharma 16
Unimedic AB – Key Competitors 17
Unimedic AB – Key Employees 18
Unimedic AB – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Unimedic AB, Pharmaceuticals & Healthcare, Key Facts 2
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Unimedic AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Unimedic AB, Deals By Therapy Area, 2012 to YTD 2018 8
Unimedic AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Unimedic Enters into Distribution Agreement with Mylan 10
Unimedic Pharma Enters into Licensing Agreement with Basilea Pharma 11
Unimedic Enters into Licensing Agreement with Martindale Pharma 12
Unimedic Acquires Miwana 13
Unimedic Acquires Cross Pharma From Medivir For USD18.6 Million 14
Unimedic Acquires Pharmadone 15
Unimedic Acquires Ergobe Pharma 16
Unimedic AB, Key Competitors 17
Unimedic AB, Key Employees 18
Unimedic AB, Subsidiaries 19

List of Figures
Unimedic AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Unimedic AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Unimedic AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ping An Insurance (Group) Company of China Ltd (601318):企業の財務・戦略的SWOT分析
    Ping An Insurance (Group) Company of China Ltd (601318) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’ …
  • Eleison Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Eleison Pharmaceuticals LLC (Eleison Pharmaceuticals) is a drug development company that acquires, develops, and commercializes clinical stage drug candidates for orphan cancers. The company’s pipeline products include glufosfamide and inhaled lipid-complexed cisplatin. Its glufosfamide is a …
  • Sunland Group Ltd:企業の戦略・SWOT・財務情報
    Sunland Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Sunland Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Genuine Parts Company (GPC):企業の財務・戦略的SWOT分析
    Genuine Parts Company (GPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • C&C Group plc:企業の戦略・SWOT・財務分析
    C&C Group plc - Strategy, SWOT and Corporate Finance Report Summary C&C Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Spur Corporation Limited
    Spur Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Spur Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Red River Valley Mutual Insurance Company:企業の戦略・SWOT・財務情報
    Red River Valley Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Red River Valley Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Aeon Co., Ltd.:企業の戦略・SWOT・財務分析
    Aeon Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aeon Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • CITIC Telecom International Holdings Ltd (1883):企業の財務・戦略的SWOT分析
    CITIC Telecom International Holdings Ltd (1883) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Eckert & Ziegler BEBIG SA (EZBG):企業の財務・戦略的SWOT分析
    Summary Eckert & Ziegler BEBIG SA (Eckert & Ziegler) a subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG, is a medical device company that produces and distributes brachytherapy and radiotherapy products. The company offers products such as permanent prostate implants, HDR afterloaders, …
  • RentPath, LLC:企業の戦略・SWOT・財務情報
    RentPath, LLC - Strategy, SWOT and Corporate Finance Report Summary RentPath, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • One Lambda Inc-医療機器分野:企業M&A・提携分析
    Summary One Lambda Inc (One Lambda), a subsidiary of Thermo Fisher Scientific Inc is a medical device company that offers laboratory products. The company develops and distributes histocompatibility typing tests and antibody detection products. Its products include HLA tissue typing trays, HLA testi …
  • Reinsurance Group of America, Incorporated:戦略・SWOT・企業財務分析
    Reinsurance Group of America, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Reinsurance Group of America, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Abcodia Ltd:企業の製品パイプライン分析2018
    Summary Abcodia Ltd (Abcodia) is a clinical stage company that offers commercial development of novel, scientifically validated tests for the early detection of cancer. The company offers Roca Test, a blood test for early ovarian cancer detection. It validates and discovers biomarkers for early diag …
  • Taiho Pharmaceutical Co Ltd:企業の戦略的SWOT分析
    Taiho Pharmaceutical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Magnus Life Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Magnus Life Ltd (Magnus) is a biomedical organization that funds, builds and manages companies to translate science into therapeutics and devices. The organization in involved in developing therapies for the treatment for obstetric conditions and pathologies of pregnancy including placental …
  • NeuroBo Pharmaceuticals Inc (NRBO):企業の財務・戦略的SWOT分析
    NeuroBo Pharmaceuticals Inc (NRBO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Gulfport Energy Corp (GPOR):企業の財務・戦略的SWOT分析
    Gulfport Energy Corp (GPOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Sunquest Information Systems Inc:企業の戦略的SWOT分析
    Sunquest Information Systems Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Safeguard Scientifics Inc (SFE):企業の財務・戦略的SWOT分析
    Summary Safeguard Scientifics Inc (Safeguard Scientifics), formerly Lancaster Corp, is a provider of finance, healthcare and digital media solutions. The company offers business intelligence and analytics for institutional/capital markets, insurance technology, regulatory and compliance technology a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆